Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodine-131 Anti-B1 Antibody in Untreated Low-Grade Non-Hodgkin's Lymphoma
NCT00996996Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 1996
- Primary completion
- Mar 1999
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of tositumomab in non-Hodgkin lymphoma (NHL), sponsored by GSK. Started Jun 1996; status: completed.
02
Drugs
tositumomab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00996996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996996.